DOI,paper_doi,paper_title_x,count_atlas,Publication_PMID,Publication_link,count_lnpdb,lnp_id,ionizable_lipid,peg_lipid,sterol_lipid,helper_lipid,lipid_molar_ratio,particle_size_nm_std,pdi_std,zeta_potential_mv_std,encapsulation_efficiency_percent_std,loading_capacity_std,target_type,nucleic_acid_sequence,peg_lipid_original,ionizable_lipid_original,helper_lipid_original,sterol_lipid_original,ionizable_lipid_smiles,peg_lipid_smiles,sterol_lipid_smiles,helper_lipid_smiles,synthesis_info,bioactivity_profile,paper_title_y,paper_authors,paper_journal,paper_year
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,202,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,213.2,0.4,1.6,52.8,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 1)",C14PEG2K,1-A2-6b,DOPE,cholesterol,NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,203,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,221.9,0.35,4.2,69.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 2)",C14PEG2K,2-A2-6b,DOPE,cholesterol,NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,204,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,185.3,0.29,6.2,57.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 3)",C14PEG2K,3-A2-6b,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid (barcoding), 0.1 mg/kg FLuc mRNA (validation); gene_expression_result: Top lung-targeting candidate; biodistribution_result: Lung-specific enrichment; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,205,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,205.6,0.29,7.1,63,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 4)",C14PEG2K,4-A2-6b,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid (barcoding), 0.1 mg/kg FLuc mRNA (validation); gene_expression_result: Top lung-targeting candidate; biodistribution_result: Lung-specific enrichment; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,206,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,219.7,0.34,'-5.4,51.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 5)",C14PEG2K,11-A2-6b,DOPE,cholesterol,NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,207,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,214.6,0.31,6.6,76.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 6)",C14PEG2K,12-A2-6b,DOPE,cholesterol,NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,208,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,182.5,0.25,'-6.2,73.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 7)",C14PEG2K,1-A2-7b,DOPE,cholesterol,NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,209,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,217,0.41,0.1,77.6,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 8)",C14PEG2K,2-A2-7b,DOPE,cholesterol,NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,210,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,150.1,0.21,4.5,71.6,"OTHER:b-DNA:FLuc mRNA weight ratio 10:1, Cas9:sgRNA weight ratio 4:1",mRNA,"firefly_luciferase, cre_recombinase, cas9, vegfr2, barcode(dna barcode 9)",C14PEG2K,3-A2-7b,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice, Ai14 mice, LLC-GFP lung tumor model; administration_route: intravenous (IV); dose: 1.0 mg/kg (barcoding), 0.1 mg/kg FLuc mRNA (validation), 0.3 mg/kg Cre mRNA, 4.0 mg/kg Cas9 mRNA/VEGFR2 sgRNA; gene_expression_result: Top performing LNP for pulmonary delivery - ~90% of total luminescence in lungs, ~60% tdTomato+ endothelial cells; biodistribution_result: Preferential lung accumulation with depletion from liver and spleen; toxicity_profile: Cell viability >85%, minimal in vivo toxicity in tissue histology","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,211,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,214.9,0.4,1.1,78.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 10)",C14PEG2K,4-A2-7b,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid (barcoding), 0.1 mg/kg FLuc mRNA (validation); gene_expression_result: Top lung-targeting candidate; biodistribution_result: Lung-specific enrichment; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,212,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,145.8,0.15,'-1.6,73,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 11)",C14PEG2K,11-A2-7b,DOPE,cholesterol,NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,213,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,143.6,0.22,'-0.4,74.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 12)",C14PEG2K,12-A2-7b,DOPE,cholesterol,NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,214,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,210.3,0.21,'-1.3,54.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 13)",C14PEG2K,1-A2-7b2,DOPE,cholesterol,NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,215,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,182.5,0.24,'-3,59.8,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 14)",C14PEG2K,2-A2-7b2,DOPE,cholesterol,NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS",cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Spleen-enriched delivery; toxicity_profile: Cell viability >85%,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,216,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,206.3,0.31,1.9,51.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 15)",C14PEG2K,3-A2-7b2,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,217,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,221.1,0.25,'-8.4,75.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 16)",C14PEG2K,4-A2-7b2,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,218,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,212.3,0.27,'-0.7,54.8,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 17)",C14PEG2K,11-A2-7b2,DOPE,cholesterol,NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,219,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,173.2,0.21,4.3,85.6,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 18)",C14PEG2K,12-A2-7b2,DOPE,cholesterol,NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,220,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,136.4,0.23,2.8,84.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 19)",C14PEG2K,1-A2-8b,DOPE,cholesterol,NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,221,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,138.3,0.21,'-0.8,75.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 20)",C14PEG2K,2-A2-8b,DOPE,cholesterol,NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid, 0.25 mg/kg FLuc mRNA (validation); gene_expression_result: Liver-targeting LNP; biodistribution_result: Liver-enriched delivery; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,222,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,116.2,0.27,'-3.6,85.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 21)",C14PEG2K,3-A2-8b,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,223,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,110.5,0.22,2.6,77.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 22)",C14PEG2K,4-A2-8b,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,224,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,149.1,0.25,'-0.1,71.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 23)",C14PEG2K,11-A2-8b,DOPE,cholesterol,NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,225,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,151.5,0.23,3.1,87.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 24)",C14PEG2K,12-A2-8b,DOPE,cholesterol,NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS",cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; gene_expression_result: Greatest enrichment in lungs but also enriched in liver and spleen; biodistribution_result: High lung enrichment but not lung-specific; toxicity_profile: Cell viability >85%,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,226,DLin-MC3-DMA,C14-PEG2000,cholesterol,DSPC,25:0.75:19.25:5,,,,,,mRNA,"cre_recombinase, cas9, vegfr2",C14PEG2K,MC3,DSPC,cholesterol,CCCCC/C=C\C/C=C\CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC/C=C\C/C=C\CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,synthesis_method: Similar to CAD LNPs; device_used: Similar to CAD LNPs; total_flow_rate_ml_min: ; flow_rate_ratio: ; aqueous_phase_composition: ; organic_phase_composition: ; mixing_time_sec: ; temperature_condition: ; post_processing: ; sterilization: ; storage_buffer: ,"animal_model: Ai14 mice, LLC-GFP lung tumor model; administration_route: intravenous (IV); dose: 0.3 mg/kg Cre mRNA, 4.0 mg/kg Cas9 mRNA/VEGFR2 sgRNA; gene_expression_result: Gold standard lung-tropic LNP control, lower performance than LNP-CAD9; biodistribution_result: Lung-targeted delivery","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,227,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,164.2,0.18,'-1.6,48.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 25)",C14PEG2K,1-A2-9b,DOPE,cholesterol,NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,228,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,186.2,0.26,5.8,66.2,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 26)",C14PEG2K,2-A2-9b,DOPE,cholesterol,NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,229,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,169.9,0.2,'-8.8,54.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 27)",C14PEG2K,3-A2-9b,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,230,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,172.1,0.23,5.2,50.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 28)",C14PEG2K,4-A2-9b,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,231,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,153.1,0.18,2.9,48.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 29)",C14PEG2K,11-A2-9b,DOPE,cholesterol,NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,232,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,135.1,0.14,9.2,69.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 30)",C14PEG2K,12-A2-9b,DOPE,cholesterol,NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,233,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,167.1,0.23,12.7,54.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 31)",C14PEG2K,1-A2-9b2,DOPE,cholesterol,NNCC1=CC(=C(O)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,234,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,164.2,0.19,'-6.4,73.2,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 32)",C14PEG2K,2-A2-9b2,DOPE,cholesterol,NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,235,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,157.1,0.17,'-10.7,53.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 33)",C14PEG2K,3-A2-9b2,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,236,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,171.9,0.1,14.7,64.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 34)",C14PEG2K,4-A2-9b2,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,237,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,166.8,0.18,10.4,57.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 35)",C14PEG2K,11-A2-9b2,DOPE,cholesterol,NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,238,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,160.8,0.16,'-4.3,58.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 36)",C14PEG2K,12-A2-9b2,DOPE,cholesterol,NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,239,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,150.3,0.19,'-9.6,39.2,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 37)",C14PEG2K,1-A3-6b,DOPE,cholesterol,NNCC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,240,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,154.9,0.13,1.2,42.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 38)",C14PEG2K,2-A3-6b,DOPE,cholesterol,NCCCCNCC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,241,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,159.3,0.14,12.6,48.8,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 39)",C14PEG2K,3-A3-6b,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCC)C(=C2)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,242,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,151.4,0.22,6.9,49.6,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 40)",C14PEG2K,4-A3-6b,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCC)C(=C2)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,243,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,135.4,0.12,9.2,46.8,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 41)",C14PEG2K,11-A3-6b,DOPE,cholesterol,NCCCN(CC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,244,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,156.2,0.16,'-3.6,37,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 42)",C14PEG2K,12-A3-6b,DOPE,cholesterol,NCCN(CC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,245,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,158.1,0.15,6.7,53.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 43)",C14PEG2K,1-A3-7b,DOPE,cholesterol,NNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,246,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,176,0.16,7.4,77.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 44)",C14PEG2K,2-A3-7b,DOPE,cholesterol,NCCCCNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,247,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,167.4,0.16,8.9,60.2,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 45)",C14PEG2K,3-A3-7b,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCC)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,248,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,159.8,0.1,2.4,66.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 46)",C14PEG2K,4-A3-7b,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCC)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,249,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,143.2,0.14,7,45.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 47)",C14PEG2K,11-A3-7b,DOPE,cholesterol,NCCCN(CC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,250,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,174.6,0.14,8.8,63.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 48)",C14PEG2K,12-A3-7b,DOPE,cholesterol,NCCN(CC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,251,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,175.2 ± 3.0,0.26 ± 0.10,1.4 ± 2.5,78.5 ± 4.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 49)",C14PEG2K,1-A3-7b2,DOPE,cholesterol,NNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,252,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,163.1 ± 6.5,0.19 ± 0.05,'-7.2 ± 2.9,78.8 ± 2.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 50)",C14PEG2K,2-A3-7b2,DOPE,cholesterol,NCCCCNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,253,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,162.2 ± 2.7,0.23 ± 0.06,6.2 ± 1.6,79.3 ± 1.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 51)",C14PEG2K,3-A3-7b2,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCC)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,254,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,159.9 ± 3.6,0.10 ± 0.06,5.2 ± 2.4,77.9 ± 6.2,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 52)",C14PEG2K,4-A3-7b2,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCC)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,255,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,162.3 ± 3.0,0.13 ± 0.02,6.4 ± 1.2,79.0 ± 3.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 53)",C14PEG2K,11-A3-7b2,DOPE,cholesterol,NCCCN(CC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,256,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,151.7 ± 4.9,0.21 ± 0.03,'-0.5 ± 1.3,79.4 ± 3.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 54)",C14PEG2K,12-A3-7b2,DOPE,cholesterol,NCCN(CC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,257,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,155.1 ± 5.2,0.16 ± 0.03,'-8.2 ± 1.4,57.8 ± 2.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 55)",C14PEG2K,1-A3-8b,DOPE,cholesterol,NNCC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,258,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,151.7 ± 3.2,0.25 ± 0.08,1.4 ± 0.9,63.9 ± 3.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 56)",C14PEG2K,2-A3-8b,DOPE,cholesterol,NCCCCNCC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS",cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; gene_expression_result: Greatest enrichment in lungs but also enriched in liver and spleen; biodistribution_result: High lung enrichment but not lung-specific; toxicity_profile: Cell viability >85%,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,259,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,162.3 ± 2.6,0.25 ± 0.10,4.7 ± 1.7,41.8 ± 2.2,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 57)",C14PEG2K,3-A3-8b,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCCC)C(=C2)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,260,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,140.8 ± 4.5,0.16 ± 0.07,8.6 ± 0.9,40.6 ± 3.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 58)",C14PEG2K,4-A3-8b,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCCC)C(=C2)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,261,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,173.5 ± 5.8,0.20 ± 0.05,'-5.6 ± 6.3,57.6 ± 3.0,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 59)",C14PEG2K,11-A3-8b,DOPE,cholesterol,NCCCN(CC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,262,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,146.7 ± 6.5,0.25 ± 0.06,5.1 ± 2.7,59.2 ± 2.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 60)",C14PEG2K,12-A3-8b,DOPE,cholesterol,NCCN(CC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,263,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,161.7 ± 6.8,0.22 ± 0.06,7.9 ± 1.9,46.9 ± 2.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 61)",C14PEG2K,1-A3-9b2,DOPE,cholesterol,NNCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,264,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,168.9 ± 3.1,0.18 ± 0.02,'-2.4 ± 0.9,65.6 ± 3.0,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 62)",C14PEG2K,2-A3-9b2,DOPE,cholesterol,NCCCCNCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,265,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,169.2 ± 5.5,0.22 ± 0.07,2.6 ± 1.8,54.3 ± 2.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 63)",C14PEG2K,3-A3-9b2,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C2)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,266,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,184.3 ± 6.4,0.12 ± 0.04,5.8 ± 3.4,48.0 ± 2.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 64)",C14PEG2K,4-A3-9b2,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C2)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,267,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,173.9 ± 5.3,0.12 ± 0.03,'-0.9 ± 1.2,47.1 ± 5.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 65)",C14PEG2K,11-A3-9b2,DOPE,cholesterol,NCCCN(CC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,268,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,154.3 ± 4.8,0.13 ± 0.07,8.7 ± 1.4,37.2 ± 3.6,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 66)",C14PEG2K,12-A3-9b2,DOPE,cholesterol,NCCN(CC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,269,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,192.2 ± 5.1,0.08 ± 0.05,'-1.2 ± 0.8,77.8 ± 3.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 67)",C14PEG2K,1-A2-7,DOPE,cholesterol,NNCC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,270,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,178.9 ± 3.7,0.18 ± 0.04,1.4 ± 1.9,84.0 ± 6.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 68)",C14PEG2K,2-A2-7,DOPE,cholesterol,NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,271,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,193.7 ± 5.0,0.07 ± 0.05,4.4 ± 4.0,74.6 ± 3.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 69)",C14PEG2K,3-A2-7,DOPE,cholesterol,NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,272,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,181.2 ± 3.9,0.10 ± 0.05,1.5 ± 7.5,82.2 ± 4.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 70)",C14PEG2K,4-A2-7,DOPE,cholesterol,NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,273,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,195.1 ± 6.3,0.12 ± 0.04,8.6 ± 15.5,81.0 ± 4.8,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 71)",C14PEG2K,11-A2-7,DOPE,cholesterol,NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC)CCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,274,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,181.8 ± 4.8,0.11 ± 0.09,13.2 ± 0.4,79.8 ± 5.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 72)",C14PEG2K,12-A2-7,DOPE,cholesterol,NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC)CCCN,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,275,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,203.4 ± 4.9,0.18 ± 0.09,3.8 ± 1.4,85.2 ± 4.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 73)",C14PEG2K,1-A2-6,DOPE,cholesterol,NNCC1=CC(=C(O)C(=C1)OC(=O)CCCCCC)OC(=O)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; gene_expression_result: Spleen-enriched delivery; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,276,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,174.0 ± 5.5,0.23 ± 0.05,7.9 ± 1.3,81.2 ± 2.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 74)",C14PEG2K,5-A2-6b,DOPE,cholesterol,CN(C)CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,277,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,164.2 ± 5.7,0.13 ± 0.09,6.5 ± 0.9,85.1 ± 2.8,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 75)",C14PEG2K,9-A2-6b,DOPE,cholesterol,CCCCCCCC(CCCN)NCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,278,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,143.6 ± 8.7,0.09 ± 0.08,3.3 ± 3.8,85.3 ± 4.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 76)",C14PEG2K,6-A2-7,DOPE,cholesterol,CN(CCCC)NCC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,279,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,195.5 ± 9.9,0.29 ± 0.07,'-9.7 ± 2.2,80.6 ± 2.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 77)",C14PEG2K,8-A2-7b,DOPE,cholesterol,CCCCCCCC(CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,280,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,179.2 ± 7.4,0.25 ± 0.09,5.8 ± 1.3,80.6 ± 3.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 78)",C14PEG2K,8-A2-7b2,DOPE,cholesterol,CCCCCCCC(CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,281,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,181.7 ± 4.9,0.24 ± 0.05,1.4 ± 0.6,83.1 ± 3.0,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 79)",C14PEG2K,5-A2-8b,DOPE,cholesterol,CN(C)CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,282,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,141.6 ± 11.1,0.21 ± 0.04,3.9 ± 2.1,82.4 ± 3.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 80)",C14PEG2K,6-A2-8b,DOPE,cholesterol,CN(CCCC)NCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,283,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,171.4 ± 4.5,0.16 ± 0.04,6.7 ± 2.0,78.5 ± 4.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 81)",C14PEG2K,7-A2-8b,DOPE,cholesterol,CCCCCN(CCC)NCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,284,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,155.0 ± 6.5,0.15 ± 0.05,1.5 ± 0.7,79.7 ± 3.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 82)",C14PEG2K,8-A2-8b,DOPE,cholesterol,CCCCCCCC(CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,285,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,156.3 ± 5.1,0.26 ± 0.11,6.3 ± 0.9,82.4 ± 3.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 83)",C14PEG2K,9-A2-8b,DOPE,cholesterol,CCCCCCCC(CCCN)NCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,286,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,190.5 ± 4.3,0.30 ± 0.12,4.3 ± 3.7,83.4 ± 3.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 84)",C14PEG2K,10-A2-8b,DOPE,cholesterol,NCCCCCCCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,287,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,191.3 ± 3.4,0.16 ± 0.10,4.8 ± 2.2,84.4 ± 3.6,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 85)",C14PEG2K,9-A2-9,DOPE,cholesterol,,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,288,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,190.4 ± 4.1,0.23 ± 0.08,'-1.8 ± 0.8,84.2 ± 2.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 86)",C14PEG2K,6-A3-6b,DOPE,cholesterol,CN(CCCC)NCC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,289,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,204.3 ± 5.3,0.16 ± 0.07,'-6.4 ± 0.6,81.8 ± 4.7,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 87)",C14PEG2K,10-A3-6b,DOPE,cholesterol,NCCCCCCCCCCNCC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,290,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,169.6 ± 4.5,0.19 ± 0.12,12.8 ± 0.7,86.8 ± 1.9,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 88)",C14PEG2K,7-A3-7b,DOPE,cholesterol,CCCCCN(CCC)NCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,291,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,201.5 ± 4.4,0.24 ± 0.06,2.3 ± 0.9,82.4 ± 3.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 89)",C14PEG2K,9-A3-7b,DOPE,cholesterol,CCCCCCCC(CCCN)NCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,292,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,162.3 ± 4.1,0.22 ± 0.06,'-1.7 ± 0.6,83.2 ± 4.1,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 90)",C14PEG2K,6-A3-7b2,DOPE,cholesterol,CN(CCCC)NCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,293,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,143.2 ± 6.9,0.27 ± 0.11,1.5 ± 2.6,75.9 ± 5.4,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 91)",C14PEG2K,8-A3-7b2,DOPE,cholesterol,CCCCCCCC(CCNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,294,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,126.7 ± 5.9,0.21 ± 0.09,'-1.2 ± 2.7,85.5 ± 4.5,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 92)",C14PEG2K,5-A3-8b,DOPE,cholesterol,CN(C)CCNCC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,295,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,113.9 ± 5.0,0.13 ± 0.05,'-3.1 ± 2.1,73.8 ± 4.0,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 93)",C14PEG2K,7-A3-8b,DOPE,cholesterol,CCCCCN(CCC)NCC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,296,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,115.4 ± 7.1,0.16 ± 0.08,6.7 ± 4.5,75.1 ± 2.6,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 94)",C14PEG2K,5-A3-9b2,DOPE,cholesterol,CN(C)CCNCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,297,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,109.2 ± 5.2,0.25 ± 0.05,'-3.0 ± 4.1,80.4 ± 4.3,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 95)",C14PEG2K,7-A3-9b2,DOPE,cholesterol,CCCCCN(CCC)NCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; gene_expression_result: Liver-enriched delivery; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
10.1038/s41467-024-45422-9,https://doi.org/10.1038/s41467-024-45422-9,"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models",97,38424061.0,https://www.nature.com/articles/s41467-024-45422-9,851,298,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,114.1 ± 6.7,0.16 ± 0.04,2.1 ± 1.6,84.9 ± 4.8,OTHER:b-DNA:FLuc mRNA weight ratio 10:1,mRNA,"firefly_luciferase, barcode(dna barcode 96)",C14PEG2K,10-A3-9b2,DOPE,cholesterol,NCCCCCCCCCCNCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 μm filter; sterilization: 0.45 μm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']",Nature Communications,2024.0
